TREAT Asia, amfAR - The Foundation for AIDS Research, Bangkok.
Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
AIDS. 2020 Aug 1;34(10):1527-1537. doi: 10.1097/QAD.0000000000002583.
To implement a standardized cause of death reporting and review process to systematically disaggregate causes of HIV-related deaths in a cohort of Asian children and adolescents.
Death-related data were retrospectively and prospectively assessed in a longitudinal regional cohort study.
Children under routine HIV care at sites in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam between 2008 and 2017 were followed. Causes of death were reported and then independently and centrally reviewed. Predictors were compared using competing risks survival regression analyses.
Among 5918 children, 5523 (93%; 52% male) had ever been on combination antiretroviral therapy. Of 371 (6.3%) deaths, 312 (84%) occurred in those with a history of combination antiretroviral therapy (crude all-cause mortality 9.6 per 1000 person-years; total follow-up time 32 361 person-years). In this group, median age at death was 7.0 (2.9-13) years; median CD4 cell count was 73 (16-325) cells/μl. The most common underlying causes of death were pneumonia due to unspecified pathogens (17%), tuberculosis (16%), sepsis (8.0%), and AIDS (6.7%); 12% of causes were unknown. These clinical diagnoses were further grouped into AIDS-related infections (22%) and noninfections (5.8%), and non-AIDS-related infections (47%) and noninfections (11%); with 12% unknown, 2.2% not reviewed. Higher CD4 cell count and better weight-for-age z-score were protective against death.
Our standardized cause of death assessment provides robust data to inform regional resource allocation for pediatric diagnostic evaluations and prioritization of clinical interventions, and highlight the continued importance of opportunistic and nonopportunistic infections as causes of death in our cohort.
实施标准化死因报告和审查流程,系统分解亚洲儿童和青少年艾滋病毒相关死亡的原因。
在一项纵向区域队列研究中,回顾性和前瞻性评估与死亡相关的数据。
在 2008 年至 2017 年间,柬埔寨、印度、印度尼西亚、马来西亚、泰国和越南的常规艾滋病毒护理点对儿童进行了随访。报告了死因,然后进行了独立和集中审查。使用竞争风险生存回归分析比较了预测因素。
在 5918 名儿童中,5523 名(93%;52%为男性)曾接受过联合抗逆转录病毒治疗。在 371 例(6.3%)死亡中,312 例(84%)发生在曾接受过联合抗逆转录病毒治疗的儿童中(粗全因死亡率为 9.6/1000 人年;总随访时间为 32361 人年)。在这一组中,死亡时的中位年龄为 7.0(2.9-13)岁;中位 CD4 细胞计数为 73(16-325)个/μl。最常见的死因是未明确病原体引起的肺炎(17%)、结核病(16%)、败血症(8.0%)和艾滋病(6.7%);12%的原因不明。这些临床诊断进一步分为艾滋病相关感染(22%)和非感染(5.8%)、非艾滋病相关感染(47%)和非感染(11%);12%原因不明,2.2%未审查。较高的 CD4 细胞计数和较好的体重年龄 z 评分是死亡的保护因素。
我们的标准化死因评估提供了可靠的数据,为儿科诊断评估的区域资源分配以及临床干预的优先排序提供了信息,并强调了机会性和非机会性感染作为我们队列中死亡原因的持续重要性。